Intravenous pulses of methylprednisolone for systemic lupus erythematosus


Badsha, Humeira and Edwards, Christopher J. (2003) Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Seminars in Arthritis and Rheumatism, 32, (6), 370-377. (doi:10.1053/sarh.2002.50003).

Download

Full text not available from this repository.

Original Publication URL: http://dx.doi.org/10.1053/sarh.2002.50003

Description/Abstract

Background: Intravenous (IV) pulses of methylprednisolone (MEP) commonly are used to treat severe manifestations of systemic lupus erythematosus (SLE). However, despite wide use of this treatment the best dose, timing, and the situations in which this treatment should be used remain largely anecdotal. Aim: To review the mechanisms of action and evidence for clinical use of IV MEP in the treatment of SLE.Method: The literature on MEP use in SLE from 1966 to 2002, using PubMed from the National Library of Medicine, was reviewed. Results: As with other modes of corticosteroid administration, IV MEP has significant anti-inflammatory and immunosuppressive actions. These actions have been shown to be effective in treating SLE in clinical trials, for lupus nephritis. The studies are mainly uncontrolled and retrospective. Long-term observations from a few double-blind prospective trials suggest that monthly pulses of MEP, in addition to IV cyclophosphamide, may be useful. Pulse MEP is beneficial for several serious manifestations of SLE, such as neuro-psychiatric lupus, pulmonary hemorrhage, severe blood dyscrasias, cardiomyopathy, and vasculitis. However, significant side effects may occur, mostly infections, which are worse in patients with hypoalbuminemia. Conclusion: IV pulses of MEP rapidly immunosuppress patients with organ and/or life-threatening manifestations of SLE. However, the gold standard 1 g/day for 3 consecutive days is associated with significant infectious complications and lower doses may be just as useful.

Item Type: Article
ISSNs: 0049-0172 (print)
Related URLs:
Subjects: R Medicine > RB Pathology
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Q Science > QP Physiology
Divisions: University Structure - Pre August 2011 > School of Medicine > Developmental Origins of Health and Disease
ePrint ID: 25211
Date Deposited: 10 Apr 2006
Last Modified: 27 Mar 2014 18:14
URI: http://eprints.soton.ac.uk/id/eprint/25211

Actions (login required)

View Item View Item